New Drugs

Preliminary results from the recent CATALYST study found hypercortisolism in 24% of patients with type 2 diabetes who are screened for the condition. Given the high prevalence of hidden hypercortisolism among patients with type 2 diabetes, early identification and treatment...

The PER Postgame™ is an online, on-demand video program that brings together renowned experts in the treatment of IgA nephropathy (IgAN). In this educational program, these experts review the screening and diagnosis of IgAN utilizing a multidisciplinary approach and delve...

Recent advances in the treatment of presbyopia have focused on pharmacological agents as a novel therapeutic strategy that offers noninvasive, reversible options capable of enhancing depth of focus without altering the natural lens structure. As new and emerging pharmacological therapies...

The underlying pathophysiology of pulmonary arterial hypertension (PAH), a variant of pulmonary hypertension, originates in the pulmonary vasculature. Due to the rarity of PAH, few pediatric patients receive specialized therapy. In this video-based program, a pediatric pulmonologist and a pediatric...

This online, on-demand virtual symposium brings together renowned experts on Demodex blepharitis. In this educational program, these experts review the diagnosis and management of Demodex blepharitis, including a review of available therapies. This educational activity is an archive of the...

Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis globally and an important cause of chronic kidney disease and kidney failure in young adults. As understanding of its complex autoimmune and inflammatory mechanisms deepens, new opportunities are emerging to...

This online, on-demand virtual symposium brings together renowned experts in dry eye disease (DED). In this educational program, these experts use a case-based format to discuss the latest data regarding the management of DED and share their perspectives and best...

This online, on-demand virtual symposium brings together renowned experts in the field of schizophrenia. In this educational program, these experts discuss the rationale for muscarinic receptor modulation, clinical data, and the use of xanomeline/trospium chloride, the recently approved therapy in...

Schizophrenia represents a major psychiatric disorder characterized by symptoms that frequently compromise daily functioning and diminish overall quality of life. While effective management can lead to improved patient outcomes, many individuals continue to struggle with persistent or residual symptoms, medication...

This online, on-demand virtual symposium brings together renowned experts in treating major depressive disorder (MDD). In this educational program, these experts discuss managing patients with MDD by reviewing patient scenarios, reflecting on how to handle challenging cases, and integrating relevant...